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Abstract This paper reports on an experimental study of
dermal exposure to neat methanol in human volunteers
for the purposes of estimating percutaneous absorption
rates, permeation kinetics, baseline (pre-exposure) levels
of methanol in blood, and inter- and intrasubject vari-
ability. A total of 12 volunteers (seven men and ®ve
women) were exposed to methanol via one hand for
durations of 0 to 16 min in a total of 65 sessions, making
this the largest controlled study of percutaneous ab-
sorption for this common solvent. In each session, 14
blood samples were collected sequentially and analyzed
for methanol. These data were used to derive absorption
rates and delivery kinetics using a two compartment
model that accounts for elimination and pre-exposure
levels. The pre-exposure methanol concentration in
blood was 1.7  0.9 mg l)1, and subjects had statisti-
cally dierent mean concentrations. The maximum
methanol concentration in blood was reached 1.9 
1.0 h after exposure. Delivery rates from skin into blood
lagged exposure by 0.5 h, and methanol continued to
enter the systemic circulation for 4 h following exposure.
While in vitro studies have reported comparable lag
times, the prolonged permeation or epidermal reservoir
eect for such miscible solvents has not been previously
measured. The mean derived absorption rate, 8.1 
3.7 mg cm)2 h)1, is compatible with that found in the
other in vivo study of methanol absorption. Both in vivo
absorption rate estimates considerably exceed in vitro
estimates. The maximum concentration of methanol in
blood following an exposure to one hand lasting
20 min is comparable to that reached following inha-
lational exposures at a methanol concentration of
200 ppm, the threshold limit value-time weighted aver-
age (TLV-TWA). While variability in blood concentra-
tions and absorption rates approached a factor of two,
dierences between individuals were not statistically
signi®cant. The derived absorption and permeation rates
provide information regarding kinetics and absorbed
dose that can help to interpret biological monitoring
data and con®rm mathematical models of chemical
permeation.
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Introduction
Many chemicals can penetrate the skin's diusional
barriers and enter the systemic circulation via capillaries
at the dermo-epidermal junction, and a growing number
of studies indicate the importance of the percutaneous
exposure pathway (Mattie et al. 1994). Percutaneous
exposures can be dicult to predict, although biological
monitoring (BM) techniques provide useful tools for
many compounds in workplace and some environmental
settings, and many predictive models are available
(Anderson and Keller 1984; US EPA 1992; Horton et al.
1992; Auton et al. 1994; Wilschut et al. 1995; Roy et al.
1996). However, the interpretation of BM results and
modeling predictions depends upon many factors, in-
cluding the kinetics of uptake, the elimination, specia-
tion and partitioning of the chemicals in the body, the
pattern of exposure, and the timing of sample collection.
Measurements of absorption rates can aid the interpre-
tation of BM data and provide information helpful in
reconstructing past exposures, assessing and controlling
current exposures, and predicting future exposures.
Percutaneous absorption of chemical solutes is often
represented using a permeability coecient kp (cm h
)1)
describing the ¯ux or ¯ow of a compound across a
membrane (skin), Jm,ss (mg cm
)2 h)1) as a steady-state
diusion process following Fick's law (Grandjean 1990;
US EPA 1992)
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Jm;ss  kpDC  km=vDmDC=lm 1
where DC is the concentration dierential across the skin
(mg cm)3), km/v is the membrane/vehicle partition co-
ecient, Dm is the diusion coecient in the membrane
(cm2 h)1), and lm is the pathlength of chemical diusion
(cm). If the applied permeant concentration C (mg cm)3)
is much greater than the concentration in the skin, then
DC  C. Pathlength lm is commonly taken as the
thickness of the stratum corneum, the main barrier to
permeation, while Dm can be estimated using physical-
chemical properties of the permeant and the membrane
or, more practically, can be based on experimental ab-
sorption rates with the substitution of appropriate val-
ues for km/v, DC and lm. Parameters of this model,
speci®cally Dm and lm, must be recognized as bulk or
averaged values that only approximately describe the
complexity of chemical transport in the highly structured
skin, and Fick's law applies to very speci®c circum-
stances. Nevertheless, Eq. (1) can provide reasonable
approximations in many cases (Grandjean 1990).
The steady-state condition represented by Eq. (1) is
reached some time after the initial contact between the
permeant and the skin. The ``lag time'' s (h) required to
reach near steady-state conditions can be estimated
(Scheuplein and Blank 1971) as:
s  l2m=6Dm 2
and has been tabulated for many compounds (US EPA
1992).
Percutaneous uptake rates and lag times are deter-
mined by skin-speci®c factors, e.g., skin thickness,
hydration, temperature and condition, and compound-
speci®c factors, e.g., diusion coecient, lipophilicity,
polarity, solubility and volatility (Smith 1990; Fiserova-
Bergerova et al. 1990). The fate of a compound fol-
lowing absorption may be aected by binding to skin
tissues, metabolism in the skin, liver and elsewhere, and
partitioning among the body compartments (Wester
et al. 1987). A delay between dermal exposure and the
maximum body concentration has been attributed to
skin resistance, chemical binding, metabolism and par-
titioning (Fiserova-Bergerova et al. 1990; US EPA 1992;
Leung and Paustenbach 1994). Experimental and mod-
eling studies have noted kinetic features, e.g., the time
lag represented in Eq. (2), and an ``epidermal reservoir''
in the stratum corneum for organic chemicals (Hadgraft
1979; Southwell et al. 1984; US EPA 1992; Roy et al.
1996). The time lag has led US EPA (1992) to recom-
mend the use of Fick's second law for dynamic condi-
tions, rather than Eq. (1) (Cleek and Bunge 1993).
Permeation rates can be measured in numerous ways
(see particularly Wester and Maibach 1987; Kemp-
painen and Reifenrath 1990). In vitro techniques typi-
cally use excised skin placed in diusion cells. In vivo
techniques include measurements of surface disappear-
ance after dermal application, biological responses, and
the use of biological samples, e.g., measurements of ra-
dioactivity from labeled compounds or concentrations
of parent compounds and metabolites. Percutaneous
absorption of neat chemical liquids may not be governed
by Fick's ®rst law of steady-state diusion, and direct
in vivo skin contact measurements have been recom-
mended (Leung and Paustenbach 1994). In vivo and
in vitro measurements have shown reasonably good
agreement for some hydrophilic compounds, but poorer
agreement for very hydrophilic or lipophilic compounds
(US EPA 1992). Unfortunately, available measurements
are scarce and not standardized, and information is
generally insucient to characterize the diversity of skin
sites, intersubject variability, dierent exposure patterns,
and permeation kinetics. For ethical and practical rea-
sons, in vivo studies rarely use human subjects, and the
species interpolation required from animal data causes
additional uncertainty.
Materials and methods
Study design and modeling
This paper reports on an experimental study where dermal expo-
sures of methanol were administered to human volunteers. Meth-
anol's toxicity (Kavet and Nauss 1990) and possible use as a motor
fuel together suggests that dermal exposures could be widespread
and signi®cant.
To reveal permeation kinetics, the study used a series of blood
samples collected before and after dermal exposures and a simple
two compartment model representing the exposed skin and the rest
of the body. Recent physiologically based skin models have de-
picted three layers of the skin, i.e., the surface layer, stratum
corneum and viable tissue, which may be particularly applicable to
lipophillic compounds (Auton et al. 1994). However, the one-layer
model may be justi®ed given that methanol is not lipophillic. Also,
the use of complex models and indirect methods to estimate ab-
sorption is likely to result in signi®cant uncertainties given that
many model parameters are not well known.
During exposure, the absorption and permeation of the solvent
in the skin occur according to Eq. (1) at rate Jm,ss over exposed skin
area A (cm2). At each time t (min), the concentration of the solvent
in exposed skin, Cm,t (mg cm
)3), is a balance between the uptake
rate, Jm,t, and the delivery rate of the solvent from exposed skin to
blood and the rest of the body, Jb,t (mg cm
)2 h)1):
dCm;t=dt  Jm;t ÿ Jb;t=Alm 3
The rate of solvent uptake is assumed to reach steady state rapidly
during the time the hand is immersed in the solvent, thus
Jm,t = Jm,ss during the exposure. Before and after solvent immer-
sion, Jm,t = 0. O-gassing, metabolism in the exposed skin, and
other losses are assumed to be negligible. Strictly speaking, Jm,ss is a
steady-state rate; however, it can be viewed as an average rate over
the exposure duration texp (h) in the following derivation. Only
solvent ¯uxes to and from the skin reservoir are estimated, and not
the concentration in the exposed skin Cm,t, skin depth lm, or volume
of the local skin compartment, Alm.
Once in blood, the solvent may be partitioned, diluted among
body ¯uids, metabolized, and eliminated. Assumptions used to
derive delivery rate Jb,t from concentration measurements in blood
include: (1) Jb,t = 0 prior to skin immersion; (2) Jb,t is relatively
constant in short intervals so that an average rate Jb,i in time period
i can be determined; (3) mixing in general circulation and parti-
tioning in the body are fast; and (4) elimination is ®rst order with a
known rate constant. The methanol concentration in blood is as-
sumed to re¯ect the dose and body concentration since partitioning
in fatty tissues for this miscible solvent is unimportant. [Methanol's
Kow is small, 0.17, and partition coecients are near unity, e.g.,
1.3 and 1.1 for rich and slowly perfused tissues, respectively
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(Horton et al. 1992). Lipophilic compounds require dierent
treatment to account for partitioning.) With these assumptions, the
methanol concentration in the body, Ct (mg cm
)3), is governed by
dCt=dt  AJb=V ÿ kCt 4
where V is the total (distribution) volume of body ¯uids (cm3) and
k is the ®rst-order elimination rate (h)1). Flux Jb,t is likely to dier
from Jm,ss as: (1) a lag is likely due to the time for the solvent to be
transferred across the skin; (2) a Jb may have separate rate limi-
tation due to low capillary blood ¯ows, solubility limitations, and
other reasons; and (3) delivery continues after the exposure ends as
solvent in the exposed skin is only gradually depleted.
Concentrations in blood were measured 12 times after the ex-
posure started, allowing Jb,i to be estimated in 12 time periods. In
each time period, the concentration in blood can be estimated by
solving Eq. (4):
Ct  AJb;i=kV 1ÿ expÿkt ÿ ti  Ci expÿkt ÿ ti  Ce 5
where ti is the start of time period i (h), Ci is the concentration
increment above the endogenous level at time ti (mg cm
)3), and
Ce is the endogenous level of the compound (mg cm
)3). Ci may
represent levels due to some previous exposure. Ce is estimated as
the pre-exposure level using the minimum of measurements taken
10 and 15 min prior to exposure.
The area under the curve in period i, AUCi (mg l
)1 h), i.e., the




Ct dt  AJb;i=kV fDti  expÿkDti ÿ 1=kg
 Ci=k1ÿ expÿkDti
6
where Dti is the duration of the period (h) and Ce is considered to
be zero (only concentrations above endogenous levels are of inte-
rest). Then, Jb,i can be solved as:
Jb;i fAUCi  Ci=kexpÿkDti ÿ 1g kV =
fADti  expÿkDti ÿ 1=kg
7
where AUCi is calculated for each period using pairs of adjacent
concentration measurements and the trapezoidal rule,
AUCi  Ci  Ci1Dti=2: Delivery rate Jb,i accounts for initial and
endogenous concentration levels (Ci and Ce, respectively), elimi-
nation (at rate k), and dilution (into V ). The total amount of sol-
vent entering blood (calculated as
P
i1;...;12 Jb;iDti is equal to that
entering the skin over the exposure duration texp (h) (estimated as






Finally, permeability coecient Kp can be determined from Eq. (1).
In summary, Eq. (7) uses adjacent observations from the sequence
of blood samples to determine the delivery rate of methanol to
blood from exposed skin for that period, and Eq. (8) integrates
over all periods to derive the overall permeability coecient in
which absorption and permeability are assumed to occur at a
constant rate over exposure duration texp. This approach is moti-
vated by the short exposure periods and by the observed trends of
methanol concentrations.
The derived absorption and delivery rates use subject-speci®c
estimates of distribution volume V based on subject weight and
scaled from the average individual given by Guyton (1994) as
weighing 70 kg and having V  40 l of body ¯uids. A methanol
half-life of 1.56 h (Batterman et al. 1996c) was used.
Another measure of exposure is the entire area-under-the-curve,
AUC (mg l)1 h), measured in the experiment to 7 h after exposure
and de®ned as AUC Pi1;...;12 AUCi. Given the de®nition of Ci,
the AUC represents levels above the exogenous level.
Subjects and methods
The dermal exposure protocol and sample analysis procedure have
been described elsewhere (Franzblau et al. 1995; Batterman et al.
1996a, b) and only a brief description is provided here. Exposure
sessions for each volunteer were scheduled at least 1 week apart. In
a session, a subject's left hand to the distal wrist crease was placed
in a beaker of neat analytical grade methanol (99.8% pure, EM
Science, Gibbstown, N.J.) for 2, 4, 8 or 16 min. To avoid inhalation
of methanol vapor, the beaker was placed inside a laboratory fume
hood, and subjects placed their arm through a slit in plastic
sheeting that covered the hood opening. At the end of the exposure,
the hand was air dried. Blood samples were collected 15 and 10 min
prior to exposure, and at 0, 15, 30, and 45 min, 1, 1.5, 2, 3, 4, 5, 6,
and 7 h following the exposure. A similar protocol, but without
exposure, was used as a control for each subject.
Blood samples were collected into ``gray top'' Vacutainer tubes
(containing potassium oxalate and sodium ¯uoride) from the arm of
the unexposed hand. Tubes were kept on ice or refrigerated at 4 °C
until analyzed. Methanol concentrations were determined by split-
ting each blood sample into two replicates, and averaging the results
of analyses of each replicate using an automated headspace sampler,
gas chromatography and ¯ame ionization detection. For blood, the
detection limit was 0.5 mg l)1, and the precision was 3%±5%.
The hand area to the distal crease of each subject was measured
by tracing the outline of the exposed hand and measuring ®nger
and hand thickness (depth) at numerous locations. These data were
then converted into area estimates by assuming simple geometric
shapes for the palm and ®ngers. Skin conditions, e.g., roughness
and presence of damage, were noted by visual examination.
Five women (ages 41±63 years) and seven men (ages 22±54
years), participated in the experiment. Not all subjects participated
in every exposure, and several subjects repeated some exposures.
Most subjects repeated the 8-min exposure session. Subjects were
permitted to eat and drink freely during the experiment except for
alcoholic beverages during the session and the preceding 24 h.
None had known occupational or avocational exposure to meth-
anol, formic acid or formaldehyde. Two subjects were smokers
(males 11 and 14). All subjects were white except one who was
Afro-American (male 3). Subjects were instructed not to use skin
creams, moisturizers, etc., during the session. The subjects provided
written informed consent using forms and protocols approved by
the University of Michigan School of Public Health.
Results
Subject characteristics
Table 1 summarizes results of the dermal exposure ex-
periments. The number of sessions for each exposure
duration ranged from 8 (2 min duration) to 21 (8 min
duration). While the subjects varied somewhat for each
exposure duration, the average weight (80  14 kg) and
hand area (491  60 cm2) did not vary signi®cantly.
However, the number of male participants in the 2-min
session dropped from the overall average of eight to only
three, giving a sample too small to be representative.
Tables 2 and 3 present additional results, showing results
grouped by subject and sex, respectively. Among the 12
subjects, hand area was highly correlated with subject
height (r = 0.92) and to a lesser degree with weight
(r = 0.40). Also, males in the study were younger and
generally had greater hand area, weight and height than
females.
Several subjects had rough to very rough skin, par-
ticularly males 1 and 11. Three subjects (males 1, 12 and
13) had skin damage at ®nger tips, apparently due to nail-
biting. After especially the longer exposures, the exposed
hand was temporarily whitened in color and very dry.
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Baseline concentrations
The two pre-exposure measurements for a subject in a
particular session were generally similar. For individual
sessions, baseline methanol levels averaged 1.7 
0.9 mg l)1 (n = 65) and ranged from 0.4 to 4.7 mg l)1
(Table 1). Average baseline levels among the 12 subjects
diered signi®cantly (P  0:0001) and means ranged
from 0.9 to 2.9 mg l)1 (Table 2). The average baseline
level for females (2.4  0.8 mg l)1) was signi®cantly
Table 2 Subject characteristics and study results averaged by
subject. Maximum concentrations and AUC corrected for baseline.
Coecients of variation (COV) are calculated for maximum and
AUC for 8-min dermal exposure, and are based on two sessions for
each subject, except for subjects 5, 4 and 27 (one session each). Skin
damage: R rough, R very rough, B = apparent nail biting; n
sample size
Subject number, males Subject number, females Mean
1 3 5 11 12 13 14 4 24 25 26 27
Age (years) 32 30 54 30 22 33 26 49 54 41 63 53 41
Weight (kg) 87 103 70 80 74 86 63 66 70 79 63 105 79
Height (cm) 183 191 174 186 183 173 174 169 167 166 164 164 174
Hand area (cm2) 514 600 522 532 531 502 511 422 440 407 447 409 486
Skin condition R+, B R R R+ B B ± R ± ± R R ±
Baseline concentration (mg l)1)
Mean 1.6 1.7 2.2 0.9 0.9 1.0 1.1 1.9 2.3 2.7 2.9 1.9 1.7
SD 0.7 0.5 1.1 0.3 0.1 0.5 0.5 0.4 0.5 1.5 1.1 0.6 0.7
COV (%) 47.0 32.6 48.4 39.9 11.4 49.2 43.8 21.7 21.2 56.4 36.2 34.2 36.9
n 7 7 6 5 5 5 5 6 4 5 5 5 5.4
Maximum concentration (mg l)1)
0 min 0.7 1.3 1.2 0.5 0.5 2.3 0.2 1.3 0.7 )0.1 0.3 0.4 0.8
2 min 3.7 3.7 2.9 ± ± ± ± 3.5 2.9 1.6 1.4 2.2 2.7
4 min 3.3 3.1 1.9 5.9 1.8 2.5 2.3 2.2 ± ± ± 2.3 2.8
8 min 9.2 5.4 3.7 6.0 4.4 6.5 7.1 3.1 8.4 4.4 3.6 7.7 5.8
16 min 16.5 11.9 9.1 12.6 11.6 13.3 12.5 10.1 ± 8.1 10.5 10.6 11.5
AUC (mg l)1 h)
0 min )4.8 3.4 0.7 0.3 0.3 1.1 )2.5 3.7 0.8 )2.6 )1.7 )1.8 )0.3
2 min 14.2 13.3 13.2 ± ± ± ± 7.1 7.4 4.6 4.2 6.4 8.8
4 min 10.3 12.8 3.3 23.0 3.4 10.5 7.1 10.0 ± ± ± 4.2 9.4
8 min 27.8 24.0 20.6 24.8 20.8 21.1 19.5 11.1 25.3 16.5 12.8 21.4 20.5
16 min 55.3 30.7 47.2 54.6 44.6 36.0 45.2 48.4 ± 17.4 39.0 34.4 41.2
Table 1 Subject characteristics, baseline concentrations, maximum concentrations, and area under the curve (AUC), all averaged by
exposure duration. Maximum concentration and AUC corrected for baseline concentration. Righthand column (All ) shows statistics for
all exposure durations (n  65). Standard deviation in parentheses
Exposure duration All
0 min 2 min 4 min 8 min 16 min
Sample size 12 8 13 21 11 65
Male (%) 58 38 77 62 64 62
Weight (kg) 79 (14) 80 (16) 82 (15) 79 (13) 80 (15) 80 (14)
Hand area (cm2) 486 (60) 470 (69) 508 (60) 492 (58) 491 (61) 491 (60)
Baseline concentration (mg l)1)
Mean 1.6 (0.8) 2.1 (1.3) 1.6 (0.8) 1.6 (0.6) 2.0 (1.5) 1.7 (0.9)
Minimum 0.7 0.5 0.7 0.7 0.4 0.4
Maximum 3.3 4.1 3.5 2.7 4.7 4.7
Maximum concentration above baseline (mg l)1)
Mean 0.8 (0.6) 2.7 (0.9) 2.7 (1.2) 5.9 (2.4) 11.5 (2.3) ±
Minimum )0.1 1.4 0.7 2.6 8.1 ±
Maximum 2.3 3.7 5.9 12.5 16.5 ±
Lag time for maximum concentration (hours after exposure)
Mean ± 2.2 (1.3) 1.5 (0.9) 1.9 (1.1) 1.8 (0.8) 1.9 (1.0)
Minimum ± 0.8 0.5 0.8 0.8 0.7
Maximum ± 5.0 4.0 5.0 3.0 4.3
Area-under-the-curve (mg l)1 h)
Mean )0.3 (2.5) 8.8 (4.1) 9.3 (6.6) 20.9 (6.5) 41.2 (11.2) ±
Minimum )4.8 4.2 0.7 10.7 17.4 ±
Maximum 3.7 14.2 23.0 35.0 55.3 ±
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higher than that for males (1.3  0.8 mg l)1, P < 0:0001,
Table 3). Overall, baseline line measurements were quite
variable with a coecient of variation (COV) of 55%.
This variability may be attributed to both ``individual''
or intersubject variability, and to ``session'' or intra-
subject variability. The average COV among subjects was
37%. The remainder, a roughly comparable amount,
was attributed to intrasubject variability. Both sources
of variability are important if small dierences in
methanol levels are to be distinguished.
Maximum concentrations
Maximum concentrations reported are the peak meth-
anol level in blood following the exposure, corrected for
the baseline level (which is subtracted). Tables 1±3 list
maxima overall and averaged by subject and sex.
Figure 1 plots maximum concentrations versus exposure
duration, showing a strong linear relationship (r =
0.89). Moderate scatter is seen, especially for the 8-min
exposure duration where the largest number (all 12) of
subjects was tested. However, dierences in means of the
8-min maxima among subjects were not statistically
signi®cant (P  0:19 in a one-factor ANOVA). Tests for
intersubject dierences using all exposure durations si-
multaneously also showed no eect of subject (P  0:17
in a two-factor ANOVA). Based on the 8-min expo-
sures, the average intra-subject COV was 31%, com-
pared to the total (intra- plus intersubject) variability
of 41%.
While intersubject dierences in maximum concen-
trations were not statistically signi®cant, average male-
to-female ratios were fairly constant for the longer ex-
posure durations, and maximum concentrations for
males averaged 24% higher than for females (Table 3).
This statistic excludes 0- and 2-min exposure results,
since concentration increases above baseline levels were
small and peaks were not consistently detected in these
experiments. Peak concentrations for any exposure du-
ration were variable, e.g., the ranges for 8- and 16-min
exposures were 2.6±12.5 and 8.1±16.5 mg l)1, respec-
tively. Baseline variability of a few milligrams per liter
cannot account for these dierences.
Maximum concentrations occurred an average of
1.9  1.0 h after the end of the exposure (Table 1). For
individual sessions, this time had considerable variabil-
ity, especially for the 2-min exposures. Fig. 2 shows that
methanol concentrations in blood increased to near peak
levels 1 h following exposure, had a broad and ¯at
peak at 1.9 h, then decreased due to the clearance of
Table 3 Subject characteristics and study results averaged by exposure duration and sex. Ratio shows mean male:female ratio. Standard
deviation in parentheses. Standard deviation of ratio obtained by Gaussian quadrature. Asterisk denotes that average and standard
deviation excludes 0- and 2-min dermal exposure durations
Exposure duration Average
0 min 2 min 4 min 8 min 16 min
Hand area (cm2) Male 530 (32.7) 546 (47.6) 535 (35.6) 531 (32.6) 530 (32.7) 534 (36)
Female 425 (18.1) 425 (18.1) 418 (7.5) 427 (18.2) 421 (18.5) 423 (16)
Ratio 1.25 (0.09) 1.28 (0.12) 1.28 (0.09) 1.24 (0.09) 1.26 (0.10) 1.26 (0.10)
Weight (kg) Male 80 (13.0) 87 (16.1) 82 (13.4) 81 (12.7) 80 (13.0) 82.2 (13.6)
Female 76 (16.8) 76 (16.8) 79 (22.3) 74 (13.7) 78 (18.9) 76.8 (17.7)
Ratio 1.05 (0.29) 1.14 (0.33) 1.05 (0.34) 1.09 (0.26) 1.03 (0.30) 1.07 (0.30)
Baseline concentration Male 1.4 (0.9) 1.1 (0.5) 1.5 (0.9) 1.4 (0.5) 1.3 (0.9) 1.3 (0.8)
(mg l)1) Female 2.0 (0.4) 2.8 (1.2) 1.9 (0.5) 1.8 (0.5) 3.4 (1.3) 2.4 (0.8)
Ratio 0.69 (0.48) 0.38 (0.25) 0.74 (0.50) 0.78 (0.37) 0.37 (0.29) 0.59 (0.38)
Maximum concentration Male 1.0 (0.7) 3.4 (0.4) 2.9 (1.4) 6.2 (2.4) 12.5 (2.2) ±
(mg l)1) Female 0.5 (0.5) 2.3 (0.9) 2.2 (0.1) 5.5 (2.5) 9.8 (1.2) ±
Ratio 1.80 (2.22) 1.48 (0.59) 1.30 (0.61) 1.14 (0.69) 1.27 (0.27) 1.24* (0.52)
AUC (mg l)1 h) Male )0.2 (2.7) 13.6 (0.5) 9.7 (7.3) 22.8 (5.0) 44.8 (9.0) ±
Female )0.3 (2.6) 5.9 (1.5) 8.1 (3.7) 17.7 (7.6) 34.8 (13.0) ±
Ratio 0.67 (9.74) 2.29 (0.58) 1.20 (1.06) 1.29 (0.62) 1.29 (0.55) 1.26* (0.74)
Fig. 1 Maximum methanol concentrations in blood, corrected for
baseline, versus duration of neat dermal exposures to one hand. Trend
line: Y  0:668X  0:660, R2  0:79
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methanol. This pattern is especially clear for 8- and
16-min exposures.
Eects of body weight and exposed skin area on
maximum concentrations were investigated in several
analyses. If maxima and exposure durations are linearly
related, as indicated by Fig. 1, then the maximum con-
centration divided by the corresponding exposure du-
ration allows the comparison of data collected at
dierent exposure durations. The linear correlation co-
ecients of this quotient to exposed skin area and body
weight were 0.12 and 0.19, respectively. These small
coecients explain a negligible fraction of the observed
variance. Maxima had yet lower correlation to an ex-
posed skin area/body weight quotient to which doses, if
all else is constant, should be proportional. Various
multiple regression models designed to identify possible
interactions showed inconsistent or weak relationships.
To avoid errors due to the linearity assumption, analysis
was then restricted to the 8-min data. Nevertheless, re-
sults de®ed easy characterization. For example, con-
centration maxima tended to increase with body weight
(r  0:46) and decrease with hand area (r  ÿ0:07); the
opposite was expected. This analysis may indicate the
importance of inter- and intrasubject variability (e.g.,
skin dierences between subjects and skin condition),
that maxima may not be representative, and/or the
presence of confounding among the variables. Some
confounding seems likely given the limited number of
subjects and the correlation among hand area, age, sex,
and weight.
Area-under-the-curve
Statistics of the AUC are presented in Tables 1±3.
Figure 3 plots AUC versus exposure duration, showing
high correlation (r  0:89). Concentration maxima and
AUCs were highly correlated (r  0:935; n  65). Based
on the 8-min data, the average intrasubject COV was
26% and the total (intra- plus intersubject) COV was
31%. These COVs are slightly lower than comparable
statistics for the maximum. Like the maximum concen-
trations, intersubject dierences in mean AUCs were not
statistically signi®cant for the 8-min exposure (P  0:53)
or for all data (P  0:16) in one- and two-factor
ANOVAs, respectively. Using the 8-min data, the cor-
relation coecient between the AUC and hand area was
0.55, in line with expectations (unlike concentration
maxima), but still rather low. As Ravis (1990) has stated,
for the reason that the AUC represents a cumulative
measurement, it is superior to single concentration
measurements like the maximum. However, the results
indicate that a number of factors in¯uence uptake, and
we now apply the model presented earlier.
Permeation and delivery rates
Delivery rates Jb,i were estimated for each measurement
interval and session to derive the trends shown in Fig. 4.
Methanol delivery into blood began during or immedi-
ately after exposure and reached a maximum rate 0.5 h
after the exposure. Over the next several hours, delivery
Fig. 2 Methanol concentrations in blood (mg l)1) before and follow-
ing neat dermal exposures of 2-, 4-, 8- and 16-min duration. Line
indicates mean; error bars show standard deviation; points indicate
extrema
Fig. 3 Area-under-the-curve (concentration±time product), corrected
for baseline, versus duration of the exposure to one hand. Trend line:
Y  2:54X  0:533, R2  0:80
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rates gradually decreased. While the 2-and 4-min exper-
iments showed a degree of scatter, trends were similar.
The maximum delivery rates increased with exposure
duration and reached 1.25 mg cm)2 h)1 in the 16-min
experiments (Table 4).
To further illustrate transient behavior, trend lines in
Fig. 4 were scaled to their corresponding maximum
(Table 4) and plotted in Fig. 5. Trends of the scaled
delivery rates (points) and the average (line) were similar
and showed no eect of exposure duration. The decrease
0.5 h after exposure was ®t to an exponential model with
a half-life of 0.75 h (continuous line in Fig. 5). This
model and the data indicate that delivery of methanol
into blood continued for 4 h after the exposure ceased.
Typically, permeation is expressed as the average
uptake rate into skin from a solvent reservoir over the
duration of the exposure, rather than as a possibly slow
and prolonged delivery rate through skin and into
blood. Equation (8) was used to obtain the steady-state
absorption rate consistent with this terminology and
Eq. (1). The derived absorption rate averaged 8.1 
3.7 mg cm)2 h)1 and was consistent across exposure
durations. The variability of the rate, calculated as the
standard deviation across sessions at each exposure
duration (Table 4), includes inter- and intrasubject
variability.
Table 4 also lists the total methanol uptake for the
``average'' subject using the experimental estimate and
two literature estimates. The experimental estimate uses
the derived absorption rate and the average exposed skin
area. The ®rst literature estimate is based on an in vitro
study by Southwell et al. (1984) which used eight tests of
unsupported, elderly, Caucasian, midline abdominal
skin in a glass diusion cell held at 30 °C where an av-
erage absorption rate of 1.27 mg cm)2 h)1 was found
(converted from the permeation rate reported). The
second literature estimate is based on an in vivo study by
Dutkiewicz et al. (1980) which used 22 tests of three
subjects where methanol was applied in a closed cell to
forearm skin for 15 to 60 min. The average absorption
rate measured was 11.7 mg cm)2 h)1, close to 10 times
Southwell's in vitro rate. The uptake based on the de-
rived absorption rates is between the two literature es-
timates; the best-estimate rate (8.1 mg cm)2 h)1) is close
to that of Dukiewicz et al. (1980). Finally, for demon-
stration purposes only, Table 4 shows a crude uptake
Fig. 4 Derived delivery rates of methanol versus time after exposure
for 2-, 4-, 8- and 16-min exposure durations
Table 4 Derived delivery and
absorption rates, averaged by
exposure duration and sex. To-
tal uptake estimated for ``aver-
age'' subject (80 kg, 491 cm2
exposed skin area) calculated
using experimental results and
two literature values
Parameter Exposure duration (min) Average
2 min 4 min 8 min 16 min
Maximum delivery rate (mg cm)2 h)1) 0.18 0.38 0.75 1.25 ±
Absorption rate (mg cm)2 h)1)
Average 8.71 6.93 7.74 8.94 8.08
SD (4.70) (4.97) (2.80) (2.29) (3.69)
Total absorption (mg)
Using absorption rate 143 227 507 1170 ±
Southwell et al. (1993) 21 41 83 166 ±
Dukiewicz et al. (1984) 188 376 753 1506 ±
Using Maximum Concentrationa 129 129 279 543 ±
a Total mass of methanol in body (mg) based on maximum concentration and distribution volume
Fig. 5 Normalized delivery rates (shown as points), average trend,
and exponential model ®t to 4- to 16-min data. Exponential model has
a 0.75 h half-life. Normalized to maximum rate for each duration, as
shown in Table 4
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measure based on the maximum concentration in blood
multiplied by the body volume. As this calculation does
not account for elimination and kinetics, the true uptake
is considerably underestimated. Thus, such estimates
should not be used to estimate dose.
Lag time estimates
The lag time necessary to reach the maximum perme-
ation rate can be interpreted using Eqs. (1 and 2). The
thickness of the stratum corneum on the hand varies
widely, from 400 lm on the palm to a 49 lm on the back
of the hand (Scheuplein and Blank 1971). (Note that
these thicknesses considerably exceed those at most
other skin sites, which range from 10 to 40 lm.) By
substituting the average permeation rate (8.1 cm)2 h)1)
and a lag time s of 30 min in Eqs. (1) and (2), the esti-
mated eective pathlength lm is 307 lm. Alternatively,
lag times may be bracketed for lm ranging from 400 to
49 lm (for the palm and back of the hand, respectively),
giving 5 min < s < 40 min. These estimates ignore ef-
fects of the viable epidermis and the ''tortuous'' diu-
sion path in the stratum corneum. Acknowledging their
approximate nature, the observed lag times appear rea-
sonable.
Discussion
Signi®cance of dermal exposures
The biological exposure index (BEI) for urinary meth-
anol is 15 mg l)1 (ACGIH 1994), a level found, on av-
erage, after several hours of inhalational exposure at the
methanol threshold limit value (TLV), 200 ppm
(Franzblau et al. 1995). Because blood-to-urine parti-
tioning of methanol is near unity, methanol concentra-
tions in blood are similar to those in urine, although
urinary levels lag by 2 h (Batterman et al. 1996b).
Neglecting lags and partitioning, the longer (16 min)
dermal exposures in this study yielded concentrations of
methanol in blood that approached the methanol BEI,
and the dose to one individual (male 1 with the most
severe skin damage) exceeded the BEI. Extrapolating
our results, an exposure to one hand lasting 18±21 min
(depending on whether or not baseline is included)
would reach, on average, the 15 mg l)1 BEI. Thus, this
study oers good evidence that brief skin contact to
solvents can cause signi®cant exposures. Indeed, the
literature contains several case reports of severe percu-
taneous uptake and toxicity of methanol (Lazariew
1954; Downie et al. 1992).
Comparison to literature estimates
The average derived absorption rate (8.1  3.7 mg
cm)2 h)1) is compatible with that found in the other
known in vivo study (11.5 mg cm)2 h)1; Dutkiewicz et
al. 1980). This study used exposure durations from 15 to
60 min, a forearm site, and only three subjects. Some
eect of exposure duration was noted, and 15-min ex-
periments yielded a lower permeation rate (8.8 mg cm)2
h)1) very close to our results. Several factors may ac-
count for dierences between the studies. Percutaneous
absorption is signi®cantly aected by the site of appli-
cation (Maibach et al. 1971), and large dierences may
be attributable to dierences between hand and forearm
sites. Also, as discussed below, the variability of skin
appears to control intra- and intersubject uptake. Dut-
kiewicz et al. (1980) did not specify subject or skin
characteristics. Still, results are remarkably similar
considering the dierent measurement approaches used,
i.e., Dutkiewicz et al. (1980) quanti®ed absorption by
measuring the disappearance of methanol from the skin
surface; rates here are based on methanol entering and
measured in blood. The technique used by Dutkiewicz et
al. has been criticized as rates of absorption by systemic
circulation and uptake by the stratum corneum may be
combined (US EPA 1992).
Results can also be compared with those in two
in vitro studies. In addition to the study of Southwell
et al. (1984) which found a Kp = 0.0016 cm h
)1
(absorption rate = 1.27 mg cm)2 h)1), Scheuplein
and Blank (1973) also used human abdominal tissue and
determined Kp = 0.0005 cm h
)1 (absorption rate =
0.4 mg cm)2 h)1). It should be noted that Scheuplein
and Blank used a dilute (0.1 M) aqueous methanol so-
lution (the other studies used neat methanol). The varied
in vitro estimates may be explained, in part, by dier-
ences between uptake rates from dilute aqueous and neat
solutions (Leung and Paustenbach 1994). Still, South-
well's Kp value is recommended by US EPA in an in-
terim guidance document for the purpose of estimating
dermal exposures from environmental pollutants (US
EPA 1992). Our data show that absorption rates are
6 times higher for exposures to hands; Dutkiewicz esti-
mated rates 7 to 9 times higher for the forearm. The
consistency of the in vivo results suggests that the guid-
ance document requires revision.
Use and interpretation of derived absorption
and permeation rates
The derived permeation and absorption rates account
for endogenous methanol production, previous expo-
sure, elimination, and transport through the exposed
skin. Results show a lag of 30 min before the peak
methanol permeation rate is reached, and a 4 h period
following exposure of continued methanol delivery into
blood, presumably from the exposed skin acting as a
reservoir of methanol. The lag and reservoir eects were
consistent in all exposure sessions, although trends were
less clear with the short (2 and 4 min) exposures as
methanol concentrations in blood did not rise much
above baseline levels. The similarity between the (0.5 h)
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lag to reach maximum permeation rates and the post-
maximum delivery decay rate (0.75 h half-life) may in-
dicate the same controlling process, probably diusive
transport across the stratum corneum and the viable
epidermis. Estimated permeation rates and lag times
are consistent with this explanation. However, skin on
the hand is very diverse, e.g., the great variation in the
thickness of the stratum corneum between the palm and
other areas has been noted. Such dierences suggest that
mechanistic modeling may require disaggregation by
skin site, e.g., several sets of parameters for various re-
gions of the hand. While evaluations at more uniform
and better characterized skin sites might simplify anal-
ysis, the hand is one of the most likely sites of dermal
exposure.
While the ``epidermal reservoir'' is generally believed
to be active for lipophilic compounds (Hadgraft 1979),
our results suggest a similar mechanism for methanol,
which is hydrophillic. In a related study, the persistence
of high methanol ¯uxes from exposed skin to air led to
the same suggestion, a reservoir in exposed skin, i.e.,
cells, interstitial spaces of the stratum corneum, or other
structures in the dermis (Batterman et al. 1996b). If
unaccounted for, the reservoir eect can bias estimates
of clearance rates. For example, the apparent elimina-
tion half-life based on Fig. 2d is 4 h, over twice the
true rate.
If the clearance rate is slow and the permeation
through skin is rapid for a compound, then the timing of
BM measurements is not critical. Given an appropriate
BM measurement, the absorbed dose and, if exposure
characteristics are known, permeation and absorption
rates can be estimated. This is only approximately true
for methanol. The trend of methanol concentrations in
blood showed a broad and relatively ¯at peak 1±3 h
following exposure due to an approximate balance be-
tween permeation and elimination. The interpretations
of BM data become dicult for compounds with
clearance times similar to or less than permeation lag
times. Calculated lag times vary over a large range, from
minutes (for acetaldehyde, ethleneimine, m-xylene) to
days (for chlordane, DDT, dieldrin, endrin, heptachlor;
US EPA 1992). For methanol, in vitro experiments show
lag times of 0.4 h for methanol (Southwell et al. 1984);
a mechanistic model indicates that 0.5 h is required to
reach steady-state permeation conditions for an acetone
solute (Shatkin and Brown 1991); and our data show a
lag time of 0.5 h for methanol permeation and 0.75 h
reservoir half-life. Without accounting for lags and
clearance, the total chemical uptake estimated using bi-
ological monitoring will be underestimated.
In practice, few occupational or environmental
studies will have the luxury of collecting blood or other
biological samples at short intervals following exposure,
and it is unlikely that pre-exposure levels will be
checked. Additionally, dermal exposures may occur at
several skin sites and at several times, and may be
combined with vapor inhalation or possibly gastroin-
testinal absorption. Pharmacokinetic models may help
to compensate for limitations of BM measurements re-
lated to clearance, permeation, and time of sampling vis-
aÁ -vis time of exposure. The advantage of the suggested
method is its ability to derive kinetics and the dose using
simple models that require few parameters. The method
is applicable to other compounds if the distribution of
the compound in the body and the elimination rate are
known.
Sensitivity of derived absorption estimates
The accuracy of the delivery rate estimate for a time
period Jb,i for an individual rests on the accuracy of the
concentration measurements that de®ne AUCi, and es-
timates of endogeneous methanol levels, ¯uid volume
and elimination rates for that individual. While vari-
ability in these terms can lead to uncertainty, trends
obtained in individual sessions were consistent. Reli-
ability increases when deriving absorption rate Jm,ss as
all of the data are used, and further when averaging
across replicate sessions and individuals.
All of the absorption rates reported depend on three
common parameters, namely, the clearance rate, the di-
lution volume (including partitioning eects), and the
area of exposed skin. To examine the sensitivity to these
parameters, Eqs. (7) and (8) can be manipulated or an
analysis can be made using experimental data. The latter
approach is easier to interpret and the following gives
results using the 8-min exposures where the sample size
was the largest. As expected, the estimated absorption
rate increases as the clearance half-life decreases, e.g.,
for (hypothetical) half-lives of 4, 3, 2, 1, and 0.5 h, the
derived absorption rates are 3.6, 4.4, 6.2, 11.6, and
22.2 mg cm)2 h)1, respectively. (All other parameters
are held at their estimated values, i.e., AUC, hand area,
volume, etc., use subject-speci®c estimates for the 8-min
data set.) The relative sensitivity in the vicinity of the
nominal study parameters is )0.5, i.e., a 1% increase in
half-life decreases the derived absorption rate by 0.5%,
indicating low sensitivity to clearance rates. Increasing
distribution volume V by 10% yields an average ab-
sorption rate of 8.51 (from the nominal 7.7) mg cm)2 h)1
and a relative sensitivity of 1.0. Thus, results are pro-
portional and moderately sensitive to V. Finally, in-
creasing skin area A by 10% decreases the average
absorption rate to 7.0 mg cm)2 h)1, giving a relative
sensitivity of )1.0. These results again show moderate
sensitivity and the expected inverse proportionality to A.
Overall, results show only modest sensitivity to the
methanol elimination rate, probably the most uncertain
parameter in the study. Recent estimates of elimination
rates for methanol are con®ned to a small range (1.5±2 h
half-life) (Batterman et al. 1996c). This small range
combined with the low sensitivity indicate that its un-
certainty has no serious eect on results. Sensitivity
analyses can be of signi®cant value for other compounds
where some or many parameters are uncertain, and thus
it can be crucial to estimate possible errors.
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Variability
This study of 12 individuals in 65 exposure sessions
represents the largest controlled study of percutaneous
methanol exposure in the literature. As such, it oers
useful information regarding the variability of pre- and
post-exposure levels. Statistically signi®cant dierences
in pre-exposure or baseline methanol levels in blood
were found between individuals, and females had higher
levels than males (2.4 vs 1.3 mg l)1). The methanol BEI
appropriately includes the ``B'' notation indicating that
the compound is ``usually present in a signi®cant
amounts in biological specimens collected from subjects
who have not been occupationally exposed'' (ACGIH
1994). (The methanol BEI also speci®es the notation Ns,
indicating that the determinant is non-speci®c and ob-
served after exposure to some other chemicals, but not
the notation Sq, which would suggest that it is a semi-
quantitative index of exposure and that quantitative
interpretation of the measurement is ambiguous.) Be-
cause sex, age, weight, hand area, and other factors were
correlated among the subjects, intersubject dierences
found here should be downplayed. In any event, baseline
concentrations were well below levels believed to be of
toxicological signi®cance and the occupational guideline.
After exposure, the methanol concentrations in blood
were highly variable. Dierences between subjects were
not statistically meaningful and no clear relationship of
dose to the exposed skin area, subject weight or other
factor was found. This variability, lack of relationship to
weight and area, and association with a qualitative ex-
amination of skin condition together suggest that skin
characteristics aecting absorption, e.g., hydration,
condition, and temperature, are the major biological
determinants aecting uptake. Further, these charac-
teristics may have varied enough over periods of weeks
to months (the study duration) to alter an individual's
uptake and to account for some of the intrasubject
variation. Indeed, the texture, moisture, etc., among the
subject's hands varied considerably, and hands were
somewhat to considerably dryer and rougher following
exposure. Subjects with the most severe pre-existing
damage to the skin tended to have the highest methanol
uptake. Damage and changes to the skin, caused by
occupation or disease which increases hydration and
temperature and reduces evaporative loss, have been
noted to increase absorption rates (Treel et al. 1992).
The observed variability is not surprising. The in vitro
tests of Southwell et al. (1984) show interspecimen
variation of 79% for methanol, higher than that found
for the other four compounds studied (34%±48%). The
same study found similar variation in lag times. While
the abdominal samples used appeared less variable than
samples taken from other anatomical sites, the authors
stated that skin changes due to excision, storage and
manipulations of specimens may have caused their re-
sults to re¯ect greater variation than in vivo studies.
Dutkiewicz et al. (1980) reported that the duration of
the exposure was another source of variation in metha-
nol absorption rates. The highest rate was found for an
exposure duration of 30±35 min; rates at 15 and 60 min
were reduced by 25%±35% from the maximum. While
no mechanism was postulated, the exposure duration of
the highest rate corresponds to the (0.5 h) lag time found
here and by Southwell et al. (1984). An exposure dura-
tion similar to the lag time may result in solvent just
saturating the stratum corneum and the shallow epi-
dermis, at which time transport to blood becomes lim-
ited by capillary blood ¯ow. In this study, derived
absorption rates for 2±16 min exposures were consistent,
although variability increased for short exposures,
mainly due to uncertainties in the blood measurement
errors and baseline estimates. Since all exposure dura-
tions were shorter than the lag time, no such eect, if it
exists, appears active in our results. Given the increas-
ingly recognized need to avoid or limit percutaneous
exposures, studies using short dermal exposures may be
the most appropriate.
Conclusion
The study has demonstrated the derivation of absorp-
tion and delivery rates from a sequence of blood mea-
surements following exposures to neat methanol.
Although dierent methods were used, the estimated
absorption rate is comparable to the other in vivo study
and considerably greater than in vitro estimates in the
literature. While very simple models are used, the de-
rived rates are based on ®rst principles and reveal ki-
netics that include lags and reservoir eects. As
elimination processes and endogenous levels are incor-
porated, the derived rates can yield correction factors
useful in biological monitoring. While the variability in
baseline levels and post-exposure responses is sizable,
concentrations in blood increase linearly with the du-
ration of the exposure, at least on average and for rel-
atively short exposures.
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